Daylight-PDT for AKs: Comparing Two Photosensitizers (BF-200 ALA and MAL)
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare the efficacy of two photosensitizers,
methyl-aminolaevulinate (MAL) and 5-aminolaevulinic nanoemulsion (BF-200 ALA) in the
treatment of facial actinic keratosis. We use randomized, double-blinded prospective study
design. The efficacy will be assessed clinically, histopathologically and
immunohistochemically.
Phase:
Phase 4
Details
Lead Sponsor:
Joint Authority for Päijät-Häme Social and Health Care